Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China

Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China

Xiao-Qi Chen,* Yun-Xia Zhao,* Chuan-Lei Zhang, Xin-Ting Wang, Xin Zhang, Xi Chen, Chang-Wei Yuan, Qing Zhao, Xin-Ju Chen Department of Gastroenterology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, 450000, People’s Republic of C...

Full description

Bibliographic Details
Main Authors: Chen XQ, Zhao YX, Zhang CL, Wang XT, Zhang X, Chen X, Yuan CW, Zhao Q, Chen XJ
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Drug Design, Development and Therapy
Subjects:
anlotinib
objective response rate
pd-1 blockades
primary hepatocellular carcinoma.
Online Access:https://www.dovepress.com/effectiveness-and-safety-of-anlotinib-with-or-without-pd-1-blockades-i-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/effectiveness-and-safety-of-anlotinib-with-or-without-pd-1-blockades-i-peer-reviewed-fulltext-article-DDDT

Similar Items